Cite
HARVARD Citation
Abecassis, A. et al. (2022). CAR‐T cells derived from multiple myeloma patients at diagnosis have improved cytotoxic functions compared to those produced at relapse or following daratumumab treatment. EJHaem. 3 (3), pp. 970-974. [Online].